Related by context. All words. (Click for frequent words.) 77 cSSSIs 74 cIAI 72 candidemia 72 cSSSI 72 tigecycline 71 daptomycin 71 methicillin resistant S. aureus 71 invasive candidiasis 70 infections cIAI 70 complicated intra abdominal 70 metastatic neuroendocrine tumors 69 acquired pneumonia HAP 69 micafungin 69 treat chronic sinusitis 69 FluCAM arm 68 nosocomial pneumonia NP 68 S. aureus bacteremia 68 Proquin XR 68 intra abdominal infections 68 doripenem 68 Sudhir Agrawal D.Phil 68 S. aureus infections 68 Noxafil 68 oropharyngeal candidiasis 68 SinuNase TM 68 Clostridium difficile associated 67 heterozygous FH 67 kidney urologic 67 UPLYSO 67 herpetic keratitis 67 lucinactant 67 thalidomide Thalomid 67 MAGE A3 ASCI 67 methicillin susceptible Staphylococcus aureus 67 Altastaph 67 enterococcal 67 esophageal candidiasis 67 tolevamer 67 Pseudomonas aeruginosa infections 67 efalizumab 67 Velcade bortezomib 67 ceftazidime 67 bacteremia 67 terlipressin 67 disease CDAD 67 ketolide antibiotic 67 Kepivance 67 cSSTI 67 Gleevec imatinib mesylate 66 INCB# [003] 66 Eraxis 66 Pemetrexed 66 reslizumab 66 posaconazole 66 pseudomembranous colitis 66 Acute Bacterial Sinusitis ABS 66 immuno compromised patients 66 staphylococcal infections 66 piperacillin tazobactam 66 Dacogen decitabine 66 acyclovir Lauriad R 66 Ceftaroline 66 pharmacokinetic interactions 66 oropharyngeal candidiasis OPC 66 acute bacterial sinusitis 66 mediastinitis 66 miconazole Lauriad ® 66 systemic fungal infections 66 invasive aspergillosis 66 vapreotide acetate 66 renal toxicity 66 AGHD 66 Civacir 66 faropenem 66 DEFLUX 66 OHR/AVR# 66 Navelbine ® 66 LymphoStat B belimumab 66 Enterococcus faecium 66 vancomycin resistant 66 Bacteremia 66 refractory gout 66 Fludara ® 66 Gleevec resistant 66 haematologic 66 aztreonam 65 toenail onychomycosis 65 invasive fungal infections 65 Chronic lymphocytic leukemia 65 liposomal amphotericin B 65 Pruvel 65 Doribax 65 sJIA 65 SPRYCEL ® 65 lumiliximab 65 drug ISA# 65 IV Busulfex 65 Enterobacter cloacae 65 Moxifloxacin 65 Omacetaxine 65 riociguat 65 Vidaza azacitidine 65 CTAP# Capsules 65 oritavancin 65 gefitinib Iressa 65 metastatic malignant 65 Vandetanib 65 Dalbavancin 65 ara C 65 CYT# potent vascular disrupting 65 Staphylococcus aureus infections 65 delafloxacin 65 radezolid 65 metastatic malignant melanoma 65 constipation OIC 65 Xelox 65 Aviptadil 65 Staphylococcus aureus S. aureus 65 acetonide FA 65 eritoran 65 candidiasis 65 carcinoid syndrome 65 sunitinib Sutent 65 Evoltra ® 65 gonococcal 65 herpes zoster shingles 65 Alinia 65 cryptococcosis 65 Pafuramidine 65 S aureus 65 hepatitis C HCV 65 resistant Staphylococcus aureus MRSA 65 catheter occlusion 65 YONDELIS 65 Ribavirin causes 65 beta 1a 65 Motavizumab 65 Telavancin 65 Tarceva TM 65 VP# [004] 65 lymphoid malignancies 65 Dacogen injection 65 Acute Radiation Syndrome ARS 65 somatostatin analogues 65 hepatic failure 65 Vibativ 65 Leukine ® 65 bacterial exacerbation 65 benign prostatic hypertrophy BPH 65 relapsed MM 65 ZYVOX 64 anidulafungin 64 BARACLUDE ® 64 itraconazole Sporanox 64 Escherichia coli Klebsiella pneumoniae 64 G#DT 64 Epratuzumab 64 IMA# 64 MGd 64 HCV infections 64 Aurograb 64 Onconase 64 Afatinib 64 NOXAFIL 64 STELARA TM 64 VFEND 64 plasma kallikrein inhibitor 64 intranasal formulation 64 superficial bladder cancer 64 fluoroquinolone antibiotic 64 SNT-MC#/idebenone 64 quinolone 64 sorafenib tablets 64 methicillin resistance 64 Gel repository corticotropin injection 64 Linezolid 64 thrombotic thrombocytopenic purpura TTP 64 overactive bladder syndrome 64 bovine thrombin 64 refractory chronic lymphocytic 64 calcineurin inhibitors 64 AEG# 64 Ceflatonin 64 FRAGMIN 64 erlotinib Tarceva ® 64 diarrhea predominant irritable 64 Infusion Reactions Severe 64 CytoFab ™ 64 docetaxel Taxotere ® 64 alvimopan 64 infective endocarditis 64 sorafenib Nexavar 64 amphotericin B 64 NXL# 64 myeloproliferative disorders 64 Abbokinase 64 causative pathogen 64 Cinquil 64 Aclidinium 64 superficial basal cell carcinoma 64 pharyngitis tonsillitis 64 oral prodrug 64 vaginal candidiasis 64 essential thrombocythemia ET 64 LEUKINE 64 Streptococcus pyogenes 64 hemorrhagic cystitis 64 mRCC 64 GW# [003] 64 Cimzia TM 64 TYGACIL 64 TORISEL 64 CA MRSA infections 64 TPI ASM8 64 interstitial pneumonia 64 Daptomycin 64 anagrelide 64 malignant ascites 64 immunocompetent patients 64 Vfend 64 Clolar ® 64 severe malignant osteopetrosis 64 Nexavar sorafenib 64 Cancidas 64 RhuDex ® 64 microbiological eradication 64 adalimumab Humira 64 Methylnaltrexone 64 SSTIs 64 macrolide antibiotic 64 SinuNase ™ 64 Platinol ® 64 trimethoprim sulfamethoxazole 64 ORENCIA ® 64 gastric adenocarcinoma 64 antibiotic ceftobiprole 64 KETEK 64 ACV1 64 QVAR 64 Genentech Rituxan 64 Fodosine 64 Alequel 64 hypervascular tumors 64 systemic lupus erythematosus psoriasis 64 Xcytrin R 64 neuroendocrine cancers 64 Alvesco R 64 non metastatic osteosarcoma 64 trastuzumab DM1 T DM1 64 intravenous iv 64 delayed CINV 64 imipenem 64 CABP 64 Vancomycin resistant 64 chronic GVHD 64 therapeutic regimens 64 aripiprazole Abilify 64 MKC# MT 64 etanercept Enbrel 64 Personalized Immunotherapy 64 K ras mutations 64 Topical Suspension 64 Streptococcus pneumoniae Haemophilus influenzae 64 PEG INTRON R 64 vWD 64 Cloretazine 64 fluoroquinolone resistance 64 Tigecycline 64 iclaprim 64 gatifloxacin 64 Warfarin Coumadin 64 PML progressive multifocal 63 pediatric Crohn disease 63 INVEGA ® 63 Alferon N 63 necrotizing pneumonia 63 NAVISTAR R 63 solithromycin 63 pharmacologic stress 63 investigational monoclonal antibody 63 bacteraemia 63 BrachySil TM 63 Irinotecan 63 proteasome inhibitor 63 S. aureus isolates 63 mupirocin 63 NSAID induced 63 bortezomib Velcade 63 MRSAid TM 63 biologic DMARD 63 p# biomarker 63 REMICADE ® 63 dasatinib Sprycel 63 ORENCIA R 63 Xanafide 63 MYCAMINE 63 Kamada AAT 63 treatment naïve genotype 63 Known hypersensitivity 63 antibody MAb 63 cephalosporin antibiotics 63 hepatorenal syndrome 63 Ceflatonin ® 63 Idiopathic Pulmonary Fibrosis 63 Sebivo 63 Ciclesonide 63 JNJ Q2 63 Radezolid 63 Hepatitis C HCV 63 Mycamine 63 LTBI 63 BENLYSTA ® 63 bronchial hyperresponsiveness 63 noninfectious uveitis 63 meropenem 63 tazobactam 63 hypereosinophilic syndrome 63 A1PI 63 Certolizumab pegol 63 oral antiviral 63 CIMZIA ™ 63 bronchodilatory 63 SSc 63 posterior uveitis 63 MyVax R 63 thetreatment 63 cytomegalovirus infection 63 Phase IIb clinical trials 63 JAK inhibitor 63 induced macular edema 63 Actimmune ® 63 myelofibrosis polycythemia vera 63 alpha interferons 63 vidofludimus 63 acadesine 63 Severe Sepsis 63 nontuberculous mycobacteria 63 Ramoplanin 63 Angiox 63 monoclonal antibody MAb 63 PrevOnco 63 follicular lymphoma FL 63 serotype #A 63 zileuton 63 PAOD 63 infection sinusitis 63 aflibercept VEGF Trap 63 HepaGam B TM 63 bronchoalveolar lavage 63 immunocompromised patients 63 Campath ® 63 idiopathic thrombocytopenic purpura ITP 63 Neulasta R 63 Candida infection 63 allogeneic HSCT 63 Pegloticase 63 chronic HBV 63 pain palliation 63 anti angiogenic agents 63 TYZEKA 63 Aflibercept 63 NP2 Enkephalin 63 sodium stibogluconate 63 Anidulafungin 63 Raptiva ® 63 Traficet EN 63 basiliximab 63 HeFH 63 recombinant interferon 63 Lixivaptan 63 chronic HCV infection 63 severe gastroparesis 63 interferon ribavirin 63 eosinophilic pneumonia 63 Troxatyl 63 lenalidomide Revlimid 63 psoriasis Crohn disease 63 Mycograb 63 Oracea TM 63 FluCide 63 Aurexis 63 Skin Structure Infections 63 Rimantadine 63 Faropenem 63 Cethromycin 63 Fibrillex TM 63 Onalta TM 63 beta interferons 63 cidofovir 63 Silodosin 63 pemphigus vulgaris 63 Dasatinib 63 S.aureus 63 HuMax EGFr 63 Evicel 63 visilizumab 63 chemotherapy induced neutropenia 63 treatment naive genotype 63 Peginterferon alfa 2b 63 including eniluracil ADH 63 Onalta 63 Candidiasis 63 oral rivaroxaban 63 novel oral anticoagulant 63 Shigatoxin producing E. coli 63 dalbavancin 63 neovascular diseases 63 Aplidin 63 venous stasis ulcers 63 ribavirin RBV 63 antimicrobial prophylaxis 63 null responder HCV 63 glycopeptide 63 Phase Ib study 63 Thiovir 63 Lymphocytic 63 refractory CLL 63 Cloderm ® Cream 63 gadobutrol 63 carcinoid tumors 63 AA amyloidosis 63 selective modulator 63 Tindamax R 63 pouchitis 63 solid organ transplantation 63 biodefense pathogens 63 histone deacetylase HDAC inhibitor 63 tumor lysis syndrome 63 virus HCV infection 63 immunological diseases 63 busulfan 63 invasive fungal infection 63 steroid refractory ulcerative 63 nosocomial hospital 63 BAY #-# 63 PrevOnco ™ 63 cytotoxic effects 63 alefacept 63 ciclesonide 63 BAL# [002] 63 Tygacil 63 Lambert Eaton Myasthenic 63 Humate P 63 Amgen Neulasta R 63 ARCOXIA 63 BCR ABL inhibitor 63 dasatinib Sprycel ® 63 gastrointestinal perforation 63 vemurafenib 63 NATRECOR ® 63 S. aureus bloodstream infections 63 uncomplicated influenza 63 Catena ® 63 chronic HCV 63 OMNARIS HFA 63 right sided endocarditis 63 rilonacept 62 dermatophyte 62 T Pred 62 atypical Hemolytic Uremic Syndrome 62 hoFH 62 Zavesca R 62 peripheral vascular stent 62 Cytotoxic 62 MyVax ® 62 hereditary deficiency 62 indolent NHL 62 sulfamethoxazole 62 Zometa zoledronic acid 62 clevidipine 62 P aeruginosa 62 Moraxella catarrhalis 62 phase IIb clinical 62 eosinophilic asthma 62 Hepatocellular Carcinoma HCC 62 allograft rejection 62 oxypurinol 62 nephropathic cystinosis 62 immune thrombocytopenic purpura ITP 62 chronic HBV infection 62 EXJADE 62 Ganciclovir 62 vascular insufficiency 62 TELINTRA 62 Zarnestra 62 QTc prolongation 62 immunosuppressive therapies 62 Tracleer R 62 immunomodulatory therapy 62 complement inhibitor eculizumab 62 Vaprisol 62 nephrotoxicity 62 Clostridium difficile infections 62 chlamydial 62 heparin induced thrombocytopenia 62 susceptible isolates 62 Fluconazole 62 SCH # 62 prokinetic agent 62 Teriflunomide 62 Cleviprex TM clevidipine 62 OvaRex ® MAb 62 STELARA ™ 62 R sorafenib tablets 62 CytoFab 62 severe hypersensitivity reactions 62 TMP SMX 62 associated pneumonia VAP 62 pancreatic insufficiency 62 immuno modulatory 62 Acinetobacter baumannii 62 LEVAQUIN 62 lomitapide 62 sitaxsentan 62 oxaliplatin Eloxatin 62 PRTX 62 CTAP# 62 aclidinium 62 cariprazine 62 Candida infections 62 ciprofloxacin hydrochloride 62 Dementia Related Psychosis 62 ximelagatran 62 Interferon beta 62 Recombinant interferon alpha 62 ano genital warts 62 bacteremic 62 gemifloxacin 62 pheochromocytoma 62 VAPRISOL 62 thiazolides 62 PDX pralatrexate 62 INVANZ 62 receptor tyrosine kinase inhibitor 62 DOXIL 62 CCR5 tropic 62 acute peripheral arterial 62 Acute Myeloid Leukaemia AML 62 isavuconazole 62 acute coronary syndromes ACS 62 fluconazole resistant 62 bacterial respiratory infections 62 amikacin 62 MRSA Clostridium difficile 62 severe hypercholesterolemia 62 Cx# [002] 62 Icatibant 62 M. catarrhalis 62 Advagraf 62 Tezampanel 62 genotypic resistance 62 Telatinib 62 Cimzia ® certolizumab pegol 62 Safinamide 62 voriconazole 62 Respiratory Syncytial Virus RSV 62 myelodysplastic myeloproliferative diseases 62 idiopathic pulmonary fibrosis IPF 62 investigational therapies 62 HoFH 62 Oracea ® 62 Aspergillosis 62 immunomodulators 62 S. aureus infection 62 Golimumab 62 brand ciclesonide HFA 62 ethambutol 62 TRISENOX ® 62 Nilotinib 62 Myelodysplastic Syndrome MDS 62 GABHS 62 bacterial sepsis 62 Naive Patients 62 faropenem medoxomil 62 intracranial hemorrhage ICH 62 Gleevec imatinib 62 thrombolytic agent 62 methicillin resistant MRSA 62 Zingo TM 62 antithrombotic agents 62 injectable formulations 62 Nexavar tablets 62 ALI ARDS 62 Zemiva TM 62 reduce serum phosphate 62 Rilonacept 62 Muraglitazar 62 biliary tract cancer 62 mechanically ventilated patients 62 Vicinium TM 62 Stanate R 62 empiric treatment 62 polycythemia vera PV 62 OncoVex 62 viral subtypes 62 postoperative ileus POI 62 PROCHYMAL 62 postoperative ileus 62 cutaneous lupus 62 SNT MC# 62 CEQ# 62 pulmonary arterial hypertension PAH 62 interstitial pneumonitis 62 cutaneous T 62 Firazyr 62 relapsed leukemia 62 BD GeneOhm 62 ipratropium bromide 62 receiving immunosuppressive therapy 62 plasminogen activators 62 vitreoretinal disorders 62 Macrolide 62 targeted radiotherapeutic 62 antimuscarinic 62 commercialize deforolimus 62 ALK inhibitors 62 viral hemorrhagic fevers 62 Daclizumab 62 Onychomycosis 62 Natroba 62 Central Venous Catheters 62 methylnaltrexone bromide 62 ALVESCO HFA 62 MetroGel 62 PSMA ADC 62 Soriatane 62 YONDELIS R 62 imatinib Gleevec ® 62 RSD# oral 62 ESBLs 62 Liprotamase 62 trastuzumab Herceptin R 62 KRAS mutation 62 ocular allergy 62 Factor VIIa 62 Ecallantide 62 Tolvaptan 62 Hypotension 62 rifamycin 62 Complicated Skin 62 HCV infection 62 epigenetic therapies 62 pegylated alpha interferon 62 Abbott HUMIRA 62 HQK 62 successfully commercialize Iluvien 62 AA Amyloidosis 62 nucleotide analogue 62 Copegus ribavirin 62 Pegasys ® 62 either acutely decompensated 62 arterial insufficiency 62 tacrolimus ointment 62 forodesine 62 receptor inhibitor 62 beta lactam antibiotic 62 CRMD# 62 cystic fibrosis bronchiectasis 62 oral antifungal 62 Kit CD# positive 62 Levofloxacin 62 Torisel 62 Eculizumab 62 #I TM# 62 phase III isavuconazole 62 hypervirulent strain 62 Angiox ® 62 Maribavir 62 ACTEMRA TM 62 RezularTM 62 atypical hemolytic uremic syndrome 62 sargramostim 62 delivers fluocinolone acetonide FA 62 pancreatic carcinoma 62 Zenapax 62 Amphotericin B 62 Gemzar ® 62 LymphoStat B TM 62 multiple myeloma MM 62 penicillin resistant Streptococcus 62 erythema nodosum 62 Orencia abatacept 62 gallium nitrate 62 DepoCyt 62 pancreatic enzyme replacement 62 ZOLINZA 62 Gastrointestinal GI 62 Pegylated Interferon 61 pentamidine 61 protozoal 61 myeloproliferative neoplasms 61 nasal decolonization 61 retapamulin 61 REG1 61 Chronic Prostatitis 61 luliconazole 61 albiglutide 61 IAP inhibitor 61 cilengitide 61 fidaxomicin 61 Gamunex C 61 Azedra 61 opioid induced bowel dysfunction 61 pegylated interferon alfa 61 Vascugel 61 MYLOTARG 61 hyper virulent strain 61 cediranib 61 NAGS deficiency 61 fibrotic disease 61 Zorbtive TM 61 generation cephalosporin 61 huC# DM4 61 immune globulin intravenous 61 Veronate 61 nitrofurantoin 61 pharmacokinetic PK study 61 amoxicillin clavulanate 61 SinuNase 61 pyelonephritis 61 TACI Ig 61 antibiotic regimens 61 receiving XGEVA 61 MenB 61 Hepatitis C virus HCV 61 mycophenolate mofetil 61 inhibitor RG# 61 Bendamustine 61 K. pneumoniae 61 photodisinfection 61 Lupus nephritis 61 methylnaltrexone 61 pharmacokinetic equivalence 61 efaproxiral 61 Avelox 61 necrotizing 61 anti angiogenic therapy 61 oral candidiasis 61 arterial thrombosis 61 BRIM2 61 Streptococcus pneumonia 61 OMAPRO 61 hepatic encephalopathy 61 QVAR ® 61 peritumoral brain edema 61 huN# DM1 61 Methicillin 61 pegylated interferons 61 baminercept 61 mesylate 61 GRNVAC1 61 coagulation disorders 61 relapsing remitting MS RRMS 61 corticosteroid dexamethasone 61 Azathioprine 61 ZD# [001] 61 REMINYL ® 61 pancreatic neuroendocrine tumors 61 HuMax CD4 61 Tumor Response 61 interferon gamma 1b 61 Cardio Vascu Grow 61 nucleotide analog 61 Onalta ™ 61 AzaSite Plus 61 grade cervical intraepithelial 61 COPD exacerbations 61 bacterium Mycobacterium tuberculosis 61 mapatumumab 61 psoriatic arthritis PsA 61 CINTREDEKIN BESUDOTOX 61 antithrombin deficiency 61 Mipomersen 61 Klebsiella pneumoniae 61 CIMZIA TM certolizumab pegol 61 budesonide foam 61 lintuzumab SGN 61 Dyloject TM 61 Raptiva R 61 StemEx 61 trabectedin 61 MabCampath 61 leukoencephalopathy 61 Actemra tocilizumab 61 lapatinib Tykerb 61 indinavir Crixivan 61 anthracyclines taxanes 61 rFVIIa 61 elotuzumab 61 INTEGRILIN R 61 fusion enhancers 61 cancer immunotherapies 61 diaper dermatitis 61 sunitinib Sutent ® 61 griseofulvin 61 Tasigna nilotinib 61 ® bortezomib 61 Fabry Disease 61 Teflaro 61 Eisenmenger syndrome 61 ATPace TM 61 EUFLEXXA R 61 nonsevere 61 investigational humanized monoclonal antibody 61 bacterium Neisseria meningitidis 61 antithrombotics 61 pancreatic NET 61 Panzem R NCD 61 Progressive Multifocal Leukoencephalopathy 61 cephalosporin antibiotic 61 teriflunomide 61 INSPIRE Trial Phase III 61 inhalation aerosol 61 DepoDur 61 hepatitis C viral infection 61 RNAi therapeutic targeting 61 TAXOTERE ® 61 HIV coinfected 61 fusidic acid 61 Cellegesic 61 Skin Structure Infections ABSSSI 61 carbapenem 61 intravenous acetaminophen 61 RhuDex TM 61 epithelial tumors 61 AmBisome 61 lupus nephritis 61 infections bloodstream infections 61 gastrointestinal mucositis 61 MenACWY 61 BARACLUDE R 61 SCCHN 61 ribavirin therapy 61 hyperphenylalaninemia HPA due 61 pyrazinamide 61 depsipeptide 61 AFREZZA TM 61 IMiDs ® 61 Arcalyst 61 RTP #i 61 Zalypsis 61 zanolimumab 61 lexidronam injection 61 oral methylnaltrexone 61 R Saizen R 61 Virologic 61 amifampridine phosphate 61 Arikace 61 EOquin 61 rhinosinusitis 61 gastrointestinal disorders ATI 61 Bronchiectasis 61 immunodeficiency disorders 61 onychomycosis 61 P#X# antagonist 61 chronic thromboembolic pulmonary 61 bronchitis sinusitis 61 novel VDA molecule 61 CHOP chemotherapy 61 Xyfid TM 61 R bendamustine hydrochloride 61 airway hyperresponsiveness 61 PEGylated Fab fragment 61 aprepitant 61 Fidaxomicin 61 serogroup B 61 Zirgan 61 occlusion PAO 61 ADHF 61 gemcitabine chemotherapy 61 Zollinger Ellison Syndrome 61 Neulasta ® 61 Intercell vaccine 61 Diabetic Macular Edema 61 investigational antiplatelet agent 61 lenalidomide Revlimid R 61 PEG interferon 61 peginterferon alpha 2a 61 malignant neoplasms 61 MERREM 61 interferon beta therapy 61 GTC recombinant human 61 serum antibody 61 inhaled AAT 61 FS Antihemophilic Factor Recombinant 61 echinocandins 61 Alimta pemetrexed 61 recurrent glioblastoma 61 Cloretazine VNP#M 61 denileukin diftitox 61 cerebral vasospasm 61 icatibant 61 leukemia AML 61 Cardiotoxicity 61 investigational protease inhibitor 61 Ranolazine 61 CBLC# 61 basal cell carcinoma BCC 61 QLT# 61 briakinumab 61 nosocomial infection 61 Glioblastoma Multiforme 61 edifoligide E2F Decoy 61 Solazed TM 61 LymphoStat B 61 personalized immunotherapy 61 acinetobacter 61 Belerofon 61 parasitemia 61 Vesivirus 61 Nitazoxanide 61 Ception Therapeutics 61 AzaSite TM 61 TEMODAL 61 AMEVIVE 61 TBC# 61 Spiegelmer ® 61 opiate induced constipation 61 immunomodulation 61 linezolid resistant 61 salmeterol fluticasone 61 diarrhea CDAD 61 Phase Ib II 61 necrotizing pancreatitis 61 Intravenous immunoglobulin 61 secondary amenorrhea 61 Pivotal Study 61 Salmonella typhi 61 AZT zidovudine Retrovir 61 Alocrest 61 Captisol Enabled 61 trastuzumab Herceptin ® 61 smoldering multiple myeloma 61 ZACTIMA 61 Rituxan rituximab 61 atovaquone 61 dihydrochloride 61 opportunistic pathogens 61 skeletal metastases 61 potentially hepatotoxic 61 Nexavar ® 61 chronic eosinophilic leukemia 61 HBV vaccine 61 vinca alkaloid 61 macrolide antibiotics 61 oral ridaforolimus 61 RhuDex R 61 steroid dexamethasone 61 Virulizin ® 61 IRX 2 61 Doxil ® 61 pseudobulbar affect PBA 61 Atypical Hemolytic Uremic Syndrome 61 beta lactamase inhibitor 61 Hedgehog Pathway Inhibitor 61 NovaBay Aganocide compounds 61 Syndrome LEMS 61 Cryptococcus neoformans 61 neurogenic orthostatic hypotension 61 masitinib 61 paclitaxel Taxol ® 61 prucalopride 61 Mitoxantrone 61 Plaquenil 61 orally administered inhibitor 61 human rhinovirus HRV 61 cefotaxime 61 PEGylated anti 61 N. gonorrhoeae 61 Piperacillin 61 hematologic abnormalities 61 erlotinib Tarceva 61 oral FTY# 61 telithromycin 61 QuadraSphere 61 DAS# [001] 61 cysteamine bitartrate 61 Arranon 61 aspergillosis 61 docetaxel Taxotere 61 Aryplase 61 vernakalant hydrochloride 61 Glypromate 61 allergen immunotherapy 61 Hepatitis B Hepatitis C 61 Orally administered 61 eprotirome 61 Ixempra 61 P. falciparum malaria 61 Bloodstream infections 61 underlying vasculopathy 61 Cyclosporine 61 Aliskiren 61 steroid refractory 61 Telithromycin 61 Gram positive 61 Intravitreal injections 61 Simulect 61 PDE4 inhibitors